Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:BC
NYSE:BCLeisure

Brunswick (BC) Valuation Check After Return To Profit And Upgraded Analyst Ratings

Why Brunswick’s latest earnings matter for investors Brunswick (BC) is back in the spotlight after fourth quarter results showed a return to profit compared with a loss a year earlier, alongside an updated share buyback tally and a shift in analyst sentiment. See our latest analysis for Brunswick. Brunswick’s recent earnings return to profit and confirmation of sizeable buybacks appear to have supported a strong run in the shares, with a 30 day share price return of 13.06% and a 1 year total...
OB:SB1NO
OB:SB1NOBanks

A Look At SpareBank 1 Sør-Norge (OB:SB1NO) Valuation After Its Recent Share Buy-Back Programme

SpareBank 1 Sør-Norge (OB:SB1NO) has kicked off a share buy-back programme covering up to 1.0% of its stock, with repurchases so far reaching 1,881,207 shares, equal to 0.50% of issued shares. See our latest analysis for SpareBank 1 Sør-Norge. At a share price of NOK196.6, the stock has delivered a 12.34% 3 month share price return, while the 1 year total shareholder return of 31.79% and 5 year total shareholder return of 174.18% point to momentum that has been building over time. The current...
TSX:MER
TSX:MEROil and Gas

Meren Energy (TSX:MER) Valuation Check After Planned CEO Succession And Prime Oil & Gas Integration

Leadership transition at Meren Energy Meren Energy (TSX:MER) has announced a planned leadership handover, with President and CEO Dr. Roger Tucker stepping down and Chief Commercial and Operating Officer Dr. Oliver Quinn assuming these roles from February 2, 2026. See our latest analysis for Meren Energy. The leadership change comes after a strong run in the stock, with a 21.79% 3 month share price return and a 24.29% 1 year total shareholder return. The 5 year total shareholder return of...
NasdaqGS:FIGR
NasdaqGS:FIGRConsumer Finance

Assessing Figure Technology Solutions (FIGR) Valuation After A Sharp Short-Term Share Price Pullback

Event context and recent share performance Figure Technology Solutions (FIGR) has drawn fresh attention after recent trading left the stock down about 15% over the past day and roughly 29% over the past week, despite modest gains over the past month and past 3 months. See our latest analysis for Figure Technology Solutions. The sharp 1-day and 7-day share price returns, down 14.85% and 29.05% respectively, contrast with a 15.14% 3-month share price return and a positive year to date share...
TSE:4528
TSE:4528Pharmaceuticals

Ono Pharmaceutical (TSE:4528) Q3 EPS Surge Tests Bearish Margin Narratives

Ono Pharmaceutical (TSE:4528) opened Q3 2026 with revenue of ¥139,900 million, basic EPS of ¥61.42 and net income of ¥28,860 million, setting a clear marker for how its profitability is holding up. The company has seen quarterly revenue move from ¥134,223 million in Q3 2025 to ¥112,309 million in Q4 2025, then to ¥127,536 million in Q1 2026, ¥129,600 million in Q2 2026 and now ¥139,900 million in Q3 2026. Over the same period, basic EPS shifted from ¥31.83 to a loss of ¥13.93, then to ¥37.62,...
ASX:ALX
ASX:ALXInfrastructure

Assessing Atlas Arteria’s Valuation After Q4 2025 Toll Revenue Growth And Resilient Traffic Performance

What Atlas Arteria’s latest revenue update means for shareholders Atlas Arteria (ASX:ALX) has reported Q4 and full-year 2025 toll revenue growth of about 9.5%, supported by higher traffic on key French and US roads alongside recent toll increases and steady economic conditions. See our latest analysis for Atlas Arteria. Despite the solid toll revenue update, Atlas Arteria’s recent 30 day share price return of 1.23% and year to date share price return of 1.23% suggest momentum has softened...
ENXTPA:COFA
ENXTPA:COFAInsurance

Assessing COFACE (ENXTPA:COFA) Valuation After Recent Steady Performance And Undervalued Fair Value Estimate

What COFACE’s recent performance numbers tell you With no single headline event driving attention, COFACE (ENXTPA:COFA) is drawing interest as investors weigh its recent share performance and fundamentals, including a €15.75 last close and a value score of 4. See our latest analysis for COFACE. Recent share price momentum has been steady rather than sharp, with a 9.38% 90 day share price return and a 9.26% 1 year total shareholder return, alongside a much stronger 61.90% 3 year total...
TSX:RIO
TSX:RIOMetals and Mining

A Look At Rio2 (TSX:RIO) Valuation After First Gold Pour At Fenix Gold Mine

Rio2 (TSX:RIO) just reported its first official gold pour at the 100% owned Fenix Gold Mine in Chile, a key step as the project moves from construction into active production. See our latest analysis for Rio2. The first official gold pour comes after a sharp 52.05% 90 day share price return and a very large 1 year total shareholder return, even though the 7 day share price return was a 16.33% decline and the 30 day share price return was relatively flat. If this kind of early stage production...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

How Investors Are Reacting To Amazon.com (AMZN) Job Cuts And Massive AI Investments

In recent days, Amazon has moved to cut about 16,000 corporate roles, confirmed plans for a further 2,200 job reductions in Washington state starting April 28, and continued to highlight artificial intelligence as a core focus across AWS, logistics, and broader operations ahead of its February 5 earnings release. What stands out is how Amazon is pairing aggressive cost-cutting with deeper AI ties, including preliminary talks to invest up to US$50.00 billion in OpenAI and a US$38.00 billion...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Is Vera’s New Commercial Chief for Atacicept Reshaping the Investment Case for Vera Therapeutics (VERA)?

Vera Therapeutics recently appointed Matt Skelton as Chief Commercial Officer, effective January 28, 2026, elevating him from his prior role as Executive Vice President, Commercial to lead preparations around the potential launch of its lead drug candidate, atacicept, for IgA nephropathy. His background in building commercial organizations and guiding multiple drug launches at Seagen, Amgen, and Eli Lilly highlights Vera’s emphasis on experienced leadership as it moves toward possible...
TSX:BAM
TSX:BAMCapital Markets

Is Brookfield Asset Management (TSX:BAM) Pricing Reflect Recent Share Price Declines Accurately

If you are looking at Brookfield Asset Management and asking whether the recent price gives you value or just more volatility, this article is here to unpack what the numbers are really saying. The stock closed at C$64.53, with returns of an 8.1% decline over the last week, a 12.1% decline over the last month, a 12.1% decline year to date, and an 18.6% decline over the past year, while the 3 year return sits at 57.6%. Recent coverage has focused on Brookfield Asset Management's role in...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

The Bull Case For Globalstar (GSAT) Could Change Following Boingo’s Adoption Of Its XCOM 5G Platform

Globalstar recently announced that Boingo Wireless will integrate its XCOM RAN software-defined private 5G platform into Boingo’s private network infrastructure across high-traffic venues such as airports, stadiums, hospitals, and military bases. This collaboration highlights how Globalstar’s XCOM RAN can overlay existing distributed antenna systems to significantly boost network capacity while preserving broad, consistent coverage in demanding environments. Next, we’ll examine how Boingo’s...
NYSE:PNC
NYSE:PNCBanks

Is PNC Financial (PNC) Pricing Reflect Recent Gains And Regulatory Focus On Big Banks

If you are wondering whether PNC Financial Services Group is priced attractively right now, it helps to start with how the market has been treating the stock recently and what that might say about value. PNC Financial Services Group last closed at US$233.82, with returns of 4.5% over 7 days, 10.6% over 30 days, 10.6% year to date, 21.8% over 1 year, 61.8% over 3 years, and 77.2% over 5 years. This gives important context before weighing up what you are paying versus what you may be...
NYSE:EPD
NYSE:EPDOil and Gas

Enterprise Products Partners Q3 Net Margin Improvement Tests Income Bear Narratives

Enterprise Products Partners (EPD) has laid out a steady set of numbers for FY 2025 so far, with third quarter revenue at US$12.0 billion and basic EPS of US$0.61, alongside trailing 12 month revenue of US$53.0 billion and basic EPS of US$2.65 that frame the latest print in a broader context. The partnership has seen quarterly revenue move from US$13.8 billion in the third quarter of 2024 to US$12.0 billion in the third quarter of 2025, while basic EPS shifted from US$0.65 to US$0.61 over the...
NYSE:TGT
NYSE:TGTConsumer Retailing

Target (TGT) Is Up 6.9% After Board Refresh And Major Beauty Push - What's Changed

In late January 2026, Target announced its largest-ever spring beauty assortment alongside a refreshed in-store experience and beauty events, and also elected former Nike innovation chief John Hoke III and ex-HanesBrands CEO Steve Bratspies to its board, while affirming a quarterly dividend of US$1.14 per share. Together, these moves highlight Target’s push to reinvigorate merchandising authority and customer experience while adding retail veterans to help steer a broader turnaround under...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Does Cincinnati Financial’s Dividend Hike and New Risk Leaders Shift Its Capital Playbook for CINF?

On January 30, 2026, Cincinnati Financial Corporation’s board approved an 8% increase in its regular quarterly cash dividend to US$0.94 per share, payable April 15, 2026, and named three senior executives to key leadership roles across its property-casualty subsidiaries. The combination of a higher dividend and refreshed actuarial, reinsurance and finance leadership signals an emphasis on disciplined risk management alongside continued cash returns to shareholders. We’ll now examine how the...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Assessing CoreWeave (CRWV) Valuation After Recent Share Price Volatility

CoreWeave overview and recent performance snapshot CoreWeave (CRWV) has drawn fresh attention after recent trading swings, with the stock last closing at US$90.06. Short term returns are mixed, including a 1 day gain alongside a 7 day decline. See our latest analysis for CoreWeave. For context, CoreWeave’s recent moves include a 13.54% 1 month share price return alongside a 21.29% 3 month share price decline, so current momentum looks more like a reset than a steady uptrend. If CoreWeave’s...